$50.50
Manufacturer: Italy
Hyponatremia (stabilization of the tear film). Sjogren’s syndrome (stabilization of the tear film, antioxidant effect). Endocrine ophthalmopathy (stabilization of the tear film, antioxidant effect, hypoglycemia action, neurotransmitters dietary action). Climacteric syndrome (stabilization of the tear film, immunocorrective effect). Neuroparalytic keratitis (antioxidant action, hypoglycemic action, neurotransmitter action). Dry eye syndrome and its prevention (stabilization of the tear film).
Description
Lakrisek General properties
Mechanism of action
Lacrisek plus stabilizes the lipid layer of the tear film, regulates and corrects the hydration of the eye surface.
Vitamin A normalizes tissue metabolism, participates in redox processes, in the synthesis of mucopolysaccharides, proteins, lipids. Stimulates cell regeneration. Participates in the processes of photoreception (contributes to the adaptation of a person to the dark).
Vitamin E is a natural antioxidant that protects cell membranes from oxidative changes.
Phospholipids are distributed over the surface of the eye and form a film that reproduces the lipid layer, acts as a barrier, reduces the evaporation of the aqueous layer of the tear film.
Vitamins A and E have a calming and softening effect, and in combination with phospholipids, they provide functional support for the lipid component of the eyelids and stabilize the lipid component of the tear film. As liposome stabilizers, vitamins A and E help to improve symptoms of inflammatory, allergic and / or infectious origin.
The lipid component of the tear film is critical for the protective function of the tear fluid and the control of its evaporation.
Lakrisek Indications for use
Hypolacrimia (stabilization of the tear film).
Sjogren’s syndrome (stabilization of the tear film, antioxidant effect).
Endocrine ophthalmopathy (stabilization of the tear film, antioxidant effect, hypoglycemic effect, neurodiagnostic effect).
Climacteric syndrome (stabilization of the tear film, immune-correcting effect).
Neuroparalytic keratitis (antioxidant effect, hypoglycemic effect, neurotransmitter effect).
Dry eye syndrome and its prevention (stabilization of the tear film)
Lakrisek Mode of application
Instill 1 or 2 drops into the conjunctival sac 4 times a day or as directed by a physician.
Side effects
After instillation, temporary blurred vision may occur. It is recommended to wait a few seconds before starting any activity that requires clear vision. In case of any undesirable reaction, you should stop using the solution and consult your doctor.
Lakrisek Contraindications
Hypersensitivity to any component of the product or other chemically related substances.
Warning
The solution is sterile until the vial is opened.
To prevent contamination of the solution, close the bottle tightly after use and do not touch the tip of the dispenser to the eye or other objects.
If a medical device in the form of an ophthalmic solution is used for treatment, you should contact to the doctor.
Do not use in case of eye infection.
Recent Reviews